Owned by the Association for International Promotion & Study in Tumors (APSIT)
A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples
We have compared mutation analysis by DNA sequencing and Amplification Refractory Mutation Systemâ„¢ (ARMSâ„¢) for their ability to detect mutations in clinical biopsy specimens.